PRQR CIK: 1612940

ProQR Therapeutics N.V.

  • Netherlands
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions EUR
FY21:
191
FY22:
154
FY23:
121
FY24:
154
FY25:
100
(positive)
Change from FY21 to FY25
millions EUR
FY21:
18.1
FY22:
16.9
FY23:
16.9
FY24:
14.1
FY25:
12.6
Total assets
Change from FY21 to FY25
millions EUR
FY21:
210
FY22:
171
FY23:
138
FY24:
168
FY25:
113

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions EUR
FY21:
27.6
FY22:
21.0
FY23:
34.2
FY24:
38.9
FY25:
32.4
(negative)
Change from FY21 to FY25
millions EUR
FY21:
68.8
FY22:
83.7
FY23:
62.3
FY24:
40.5
FY25:
30.9
(positive)
Change from FY21 to FY25
millions EUR
FY21:
113
FY22:
66.7
FY23:
41.4
FY24:
88.6
FY25:
49.4
Total liabilities & equity
Change from FY21 to FY25
millions EUR
FY21:
210
FY22:
171
FY23:
138
FY24:
168
FY25:
113

All amounts in millions EUR Data source:SEC EDGAR